Imogen Mansfield
Stock Analyst at Cantor Fitzgerald
(1.41)
# 3,686
Out of 5,118 analysts
11
Total ratings
30%
Success rate
-1.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Imogen Mansfield
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLGL Sol-Gel Technologies | Initiated Coverage: Buy | $200 | $61.01 | +227.82% | 1 | Oct 14, 2026 | |
| OVID Ovid Therapeutics | Initiated Coverage: Buy | $6 | $2.85 | +110.53% | 1 | Oct 9, 2026 | |
| ENTX Entera Bio | Initiated Coverage: Buy | n/a | $3.14 | - | 1 | Sep 22, 2026 | |
| LHX L3Harris Technologies | Reiterated: Buy | $384 | $259.89 | +47.75% | 1 | May 19, 2026 | |
| RBC RBC Bearings | Reiterated: Buy | $615 | $474.45 | +29.62% | 1 | May 19, 2026 | |
| QTTB Q32 Bio | Initiated Coverage: Buy | n/a | $9.25 | - | 1 | May 18, 2026 | |
| SARO StandardAero | Reiterated: Buy | $35 | $27.63 | +26.67% | 3 | May 18, 2026 | |
| VSEC VSE Corporation | Reiterated: Buy | $270 | $172.81 | +56.24% | 1 | May 14, 2026 | |
| BWXT BWX Technologies | Reiterated: Hold | $212 | $119.52 | +77.38% | 1 | May 11, 2026 |
Sol-Gel Technologies
Oct 14, 2026
Initiated Coverage: Buy
Price Target: $200
Current: $61.01
Upside: +227.82%
Ovid Therapeutics
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.85
Upside: +110.53%
Entera Bio
Sep 22, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $3.14
Upside: -
L3Harris Technologies
May 19, 2026
Reiterated: Buy
Price Target: $384
Current: $259.89
Upside: +47.75%
RBC Bearings
May 19, 2026
Reiterated: Buy
Price Target: $615
Current: $474.45
Upside: +29.62%
Q32 Bio
May 18, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $9.25
Upside: -
StandardAero
May 18, 2026
Reiterated: Buy
Price Target: $35
Current: $27.63
Upside: +26.67%
VSE Corporation
May 14, 2026
Reiterated: Buy
Price Target: $270
Current: $172.81
Upside: +56.24%
BWX Technologies
May 11, 2026
Reiterated: Hold
Price Target: $212
Current: $119.52
Upside: +77.38%